6. Hepatitis Virus and Extrahepatic Manifestations -Skin, Mucosa, Muscle, and Hematopoietic Organs-

Internal Medicine

Volumn 40, Issue 2, 2001, Pages 185-189

  Sata, Michio ^a   Nagao, Yumiko ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis A virus (HAV); Hepatitis B virus (HBV); Hepatitis C virus (HCV); Lichen planus; Oral cancer

Indexed keywords

ADULT; AUTOIMMUNE DISEASE; CHILD; CORNEA ULCER; CRYOGLOBULINEMIA; HEMATOLOGIC DISEASE; HUMAN; IMMUNOLOGY; LICHEN PLANUS; MIDDLE AGED; NEOPLASM; POLYMYOSITIS; PORPHYRIA CUTANEA TARDA; PRESCHOOL CHILD; REVIEW; SJOEGREN SYNDROME; VIRUS HEPATITIS;

ADULT; AUTOIMMUNE DISEASES; CHILD; CHILD, PRESCHOOL; CORNEAL ULCER; CRYOGLOBULINEMIA; HEMATOLOGIC DISEASES; HEPATITIS, VIRAL, HUMAN; HUMANS; LICHEN PLANUS; MIDDLE AGED; NEOPLASMS; POLYMYOSITIS; PORPHYRIA CUTANEA TARDA; SJOGREN'S SYNDROME;

EID: 0035257533     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.185     Document Type: Article

References (65)

1. Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 19: 841-848, 1994.
2. Zignego AL, Brechot C. Extrahepatic manifestations of HCV infection: Facts and controversies. J Hepatol 31: 369-376, 1999.
3. Misiani R, Bellavita R, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryogloblinemia. Ann Intern Med 117: 573-577, 1992.
4. Ferri C, Greco F, Longombardo G, et al. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 19: 417-420, 1991.
5. Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106: 1291-1300, 1994.
6. Tanaka K, Aiyama T, Imai J, Morishita Y, Fukatsu T, Kakumu S. Serum cryoglobulin and chronic hepatitis C virus disease among Japanese patients. Am J Gastroenterol 90: 1847-1852, 1995.
7. Fayyazi A, Schott P, Hartmann H, et al. Clinical, biochemical, and histological changes in hepatitis C virus infection-associated cryoglobulinemia. Z Gastroenterol 35: 921-928, 1997.
8. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327: 1490-1495, 1992.
9. Gianotti F. Papular acrodermatitis of childhood and other papulo-vesicular acro-located syndromes. Br J Dermatol 100: 49-59, 1979.
10. Herrero C, Vicente A, Bruguera M, et al. Is hepatitis C infection a trigger of porphyria cutanea tarda? Lancet 341: 788-789, 1993.
11. Ferri C, Baicchi U, la Civita L, et al. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 23: 851-855, 1993.
12. Hussain I, Hepburn NC, Jones A, O'Rourke K, Hayes PC. The association of hepatitis C viral infection with porphyria cutanea tarda in the Lothian region of Scotland. Clin Exp Dermatol 21: 283-285, 1996.
13. Tsukazaki N, Tanaka K, Irifune H, et al. Relationship between porphyria cutanea tarda (PCT) and viral hepatitis. J Dermatol 21: 411-414, 1994.
14. Takikawa H, Yamazaki R, Shoji S, et al. Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of hepatitis C complicated with porphiria cutanea tarda. J Hepatol 22: 249-250, 1995.
15. Okano J, Horie Y, Kawasaki H, et al. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis C. Hepatogastroenterology 44: 525-528, 1997.
16. Rebora A, Patri P, Rampini E, et al. Erosive lichen planus and cirrhotic hepatitis. Ital Gen Rev Dermatol 15: 123-131, 1978.
17. Rebora A. Lichen planus and the liver. Lancet 2: 805-806, 1981.
18. Jubert C, Pawlotsky JM, Pouget F, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch. Dermatol 130: 73-76, 1994.
19. Gandolfo S, Carbone M, Carrozzo M, Gallo V, et al. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? a report of 10 cases. J Oral Pathol Med 23: 119-122, 1994.
20. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 25: 910-914, 1995.
21. Nagao Y, Sata M, Fukuizumi K, Tanikawa K, Kameyama T. High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. Hepatol Res 8: 173-177, 1997.
22. Nagao Y, Sata M, Itoh K, Tanikawa K, Kameyama T. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 26: 495-498, 1996.
23. Nagao Y, Sata M, Abe K, Tanikawa K, Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol 32: 324-329, 1997.
24. Nagao Y, Sata M, Tanikawa K, Kameyama T. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin. Kansenshogaku Zasshi 69: 940-943, 1995.
25. Nagao Y, Sata M, Suzuki H, Tanikawa K, Itoh K, Kameyama T. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection. J Gastroenterol 31: 691-695, 1996.
26. Nagao Y, Sata M, Noguchi S, et al. GB virus infection in patients with oral cancer and oral lichen planus. J Oral Pathol Med 26: 138-141, 1997.
27. Nagao Y, Kameyama T, Sata M. Hepatitis C virus RNA detection in oral lichen planus tissue. Am J Gastroenterol 93: 850, 1998.
28. Nagao Y, Sata M, Noguchi S, et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 29: 259-266, 2000.
29. Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot J. Lichen planus and virus C hepatitis -disappearance of the lichen under intereron alfa therapy. Dermatology 184: 229, 1992.
30. Nagao Y, Sata M, Fukuizumi K, Harada H, Kameyama T. Oral cancer and hepatitis C virus (HCV): Can HCV alone cause oral cancer? -A case report-. Kurume Med J 43: 97-100, 1996.
31. Nagao Y, Sata M, Ide T, et al. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Eur J Clin Invest 26: 1171-1174, 1996.
32. Boccia S, Gamberini S, Dalla Libera M, Strumia R, Venturini D. Lichenplanus and interferon therapy for hepatitis C. Gastroenterology 105: 1921-1922, 1993.
33. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermuller KH. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 104: 903-905, 1993.
34. Nagao Y, Sata M, Suzuki H, Kameyama T, Ueno T. Histological improvement of oral lichen planus in patients with chronic hepatitis C treated with interferon. Gastroenterology 117: 283-284, 1999.
35. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA. Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 101: 736-745, 1994.
36. Moazami G, Auran JD, Florakis GJ, Wilson SE, Srinivasan DB. Interferon treatment of Mooren's ulcers associated with hepatitis C. Am J Ophthalmol 119: 365-366, 1995.
37. De Bandt M, Ribard P, Meyer O, et al. Type-II IgM monoclonal cryoglobulinemia and hepatitis C virus infection. Clin Exp Rheumatol 9: 659-660, 1991.
38. Rodriguez-Cuartero A, Garcia-Vera E, Gomez-Cerro A. Hepatitis C virus and Sjögren's syndrome. Infection 22: 415-416, 1994.
39. Porter SR, Scully C, Lodi G, Teo CG. Lack of an association between hepatitis C virus and Sjögren's syndrome. Oral Dis 2: 183-184, 1996.
40. Jorgensen C, Legouffe MC, Perney P, et al. Sicca syndrome-associated with hepatitis C virus-infection. Arthritis Rheum 39: 1166-1171, 1996.
41. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339: 321-323, 1992.
42. Roy KM, Bagg J. Hepatitis C virus and oral disease: a critical review. Oral Dis 5: 270-277, 1999.
43. Scott CA, Avellini C, Desinan L, et al. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren syndrome. Histopathology 30: 41-48, 1997.
44. Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 94: 233-236, 1997.
45. Harada M, Sata M, Yoshida H, et al. Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases. Int Hepatol Commun 4: 195-200, 1995
46. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 345: 1236, 1995.
47. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T. Hepatitis C infection and polymyosilis. Lancet 346: 319-320, 1995.
48. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 38: 437-439, 1995.
49. Matsumori A, Ohashi N, Hasegawa K, et al. Hepatitis C virus infection and heart disease. -A multicenter study in Japan-. Jpn Circ J 62: 389-391, 1998.
50. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96: 22-24, 1997.
51. Lorenz E, Quaisar K. Panmyelopathie nach hepatitis epidemica. Wien Med Wschr 105: 19, 1955.
52. Rubin E, Gottlieb C, Vogel P. Syndrome of hepatitis and aplastic anemia. Am J Med 45: 88-97, 1968.
53. Ide T, Sata M, Mouno R, Yamashita F, Nakano H, Tanikawa K. Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia. Am J Gastroenterol 89: 257-262, 1994.
54. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 88: 392-394, 1994.
55. Ferri C, la Civita L, Monti M, et al. Can type C hepatitis infection be complicated by malignant lymphoma? Lancet 346: 1426-1427, 1995.
56. Izumi T, Sasaki R, Miura Y, Okamoto H. Primary hepatosplenic lymphoma: association with hepatitis C virus infection. Blood 87: 5380-5381, 1996.
57. Sata M, Noguchi S, Ide T, et al. Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes. Hepatol Res 10: 66-73, 1998.
58. Silvestri F, Pipan C, Barillari G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87: 4296-4301, 1996.
59. De Vita S, Sacco C, Sansonno D, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90: 776-782, 1997.
60. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 86: 1887-1892, 1995.
61. Sikuler E, Shnaider A, Ziberman D, et al. Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol 24: 87-89, 1997.
62. Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. J Oral Pathol Med 24: 354-360, 1995.
63. Nagao Y, Sata M, Itoh K, et al. High prevalence of hepatitis C virus antibody and RNA in patients with head and neck squamous cell carcinoma. Hepatol Res 7: 206-212, 1997.
64. Yoshida M, Nagao Y, Sata M, Kusukawa J, Kameyama T. Multiple primary neoplasms and HCV infection in oral cancer patients. Hepatol Res 9: 75-81, 1997.
65. Tanaka H, Tsukuma H, Teshima H, et al. Second primary cancers following non-Hodgkin's lymphoma in Japan: Increased risk of hepatocellular carcinoma. Jpn J Cancer Res 88: 537-542, 1997.